Interferon-α effects are exaggerated when administered on a psychosocial stressor backdrop:: Cytokine, corticosterone and brain monoamine variations

被引:46
作者
Anisman, Hymie [1 ]
Poulter, Michael O.
Gandhi, Reno
Merali, Zul
Hayley, Shawn
机构
[1] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada
[2] Univ Ottawa, Royal Ottawa Hosp, Mental Hlth Res Inst, Ottawa, ON, Canada
[3] John P Robarts Res Inst, Cell Biol Res Grp, London, ON N6A 5K8, Canada
关键词
interferon; cytokine; stress; depression; monoamine; cortisol;
D O I
10.1016/j.jneuroim.2007.02.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunotherapy involving interferon-a (IFN-alpha) treatment is often accompanied by symptoms of depressive illness. These effects may stem from the direct actions of the cytokine, or may be unique to individuals undergoing considerable strain. In two experiments using CD-1 mice, we demonstrate that intraperitoneal administration of IFN-alpha dose dependently influences plasma corticosterone and sickness behaviors, and modestly influences norepinephrine turnover in brain. However, when mice are exposed to a psychosocial stressor (social disruption by transferring mice from isolated to grouped conditions, and to a moderate extent a transfer from grouped housing to isolation), the effects of IFN-alpha on sickness, plasma corticosterone and hippocampal norepinephrine, as well as on the levels of circulating IL-6, TNF-alpha and IL-10 (but not IL-1 beta or IFN-gamma) are greatly augmented. It is suggested that the depressive effects of immunotherapy in humans likewise reflects the synergistic actions of the cytokine and the ongoing distress experienced by patients. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 58 条
[1]   Effects of chronic administration of interferon α A/D on serotonergic receptors in rat brain [J].
Abe, S ;
Hori, T ;
Suzuki, T ;
Baba, A ;
Shiraishi, H ;
Yamamoto, T .
NEUROCHEMICAL RESEARCH, 1999, 24 (03) :359-363
[2]   Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features [J].
Anisman, H ;
Ravindran, AV ;
Griffiths, J ;
Merali, Z .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :182-188
[3]   Cytokines, stress and depressive illness: brain-immune interactions [J].
Anisman, H ;
Merali, Z .
ANNALS OF MEDICINE, 2003, 35 (01) :2-11
[4]  
Anisman H, 1999, ADV EXP MED BIOL, V461, P199
[5]  
ANISMAN H, 2007, HDB CLIN PSYCHOL
[6]   Genetics of the serotonergic system in suicidal behavior [J].
Arango, V ;
Huang, YY ;
Underwood, MD ;
Mann, JJ .
JOURNAL OF PSYCHIATRIC RESEARCH, 2003, 37 (05) :375-386
[7]   Social interactions, stress, and immunity [J].
Avitsur, Ronit ;
Padgett, David A. ;
Sheridan, John F. .
NEUROLOGIC CLINICS, 2006, 24 (03) :483-+
[8]   IL-6 levels decrease with SSRI treatment in patients with major depression [J].
Basterzi, AD ;
Aydemir, Ç ;
Kisa, C ;
Aksaray, S ;
Tuzer, V ;
Yazici, K ;
Göka, E .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (07) :473-476
[9]   Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system [J].
Bonaccorso, S ;
Marino, V ;
Puzella, A ;
Pasquini, M ;
Biondi, M ;
Artini, M ;
Almerighi, C ;
Verkerk, R ;
Meltzer, H ;
Maes, M .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (01) :86-90
[10]   Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms [J].
Bonaccorso, S ;
Puzella, A ;
Marino, V ;
Pasquini, M ;
Biondi, M ;
Artini, M ;
Almerighi, C ;
Levrero, M ;
Egyed, B ;
Bosmans, E ;
Meltzer, HY ;
Maes, M .
PSYCHIATRY RESEARCH, 2001, 105 (1-2) :45-55